| http://www.w3.org/ns/prov#value | - The FDA clearance provides Asterias with imminent access to the previously announced $14.3 million CIRM grant, which provides non-dilutive funding to support both the clinical trial and other product development activities for AST-OPC1.??? Help employers find you!
|
